• 946 Citations
  • 17 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Deog Kyeom Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles
Chronic Obstructive Pulmonary Disease Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
Lung Medicine & Life Sciences
Pulmonary Tuberculosis Medicine & Life Sciences
Korea Medicine & Life Sciences
Asthma Medicine & Life Sciences
Emphysema Medicine & Life Sciences
Sputum Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

  • 946 Citations
  • 17 h-Index
  • 103 Article
  • 6 Review article
  • 4 Comment/debate
  • 1 Chapter
Intensive Care Units
Cohort Studies
Multivariate Analysis
Homeless Persons
1 Citation (Scopus)

Development and validation of the COugh Assessment Test (COAT)

on behalf of the Cough Study Group of the Korean Academy of Tuberculosis and Respiratory Diseases, 1 Jun 2019, In : Respirology. 24, 6, p. 551-557 7 p.

Research output: Contribution to journalArticleResearchpeer-review


Resting hyperinflation and emphysema on the clinical course of COPD

Kim, Y. W., Lee, C. H., Hwang, H. G., Kim, Y. I., Kim, D. K., Oh, Y. M., Lee, S. H., Kim, K. U. & Lee, S. D., 6 Mar 2019, In : Scientific Reports. 9, 1, p. 3764 3764.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Chronic Obstructive Pulmonary Disease
Total Lung Capacity
Obstructive Lung Diseases
1 Citation (Scopus)

Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation

Rhee, C. K., van Boven, J. F. M., Yau Ming, S. W., Park, H. Y., Kim, D. K., Park, H. S., Ling, J. Z. J., Yoo, K. H. & Price, D. B., 1 Mar 2019, In : Journal of Allergy and Clinical Immunology: In Practice. 7, 3, p. 934-942 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Nebulizers and Vaporizers
Dry Powder Inhalers
Cost-Benefit Analysis
Metered Dose Inhalers

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): Study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

Lee, M., Mok, J., Kim, D. K., Shim, T. S., Koh, W. J., Jeon, D., Lee, T., Lee, S. H., Kim, J. S., Park, J. S., Lee, J. Y., Kim, S. Y., Lee, J. H., Jo, K. W., Jhun, B. W., Kang, Y. A., Ahn, J. H., Kim, C. K., Shin, S., Song, T. & 8 othersShin, S. J., Kim, Y. R., Ahn, H., Hahn, S., Won, H. J., Jang, J. Y., Cho, S. N. & Yim, J-J., 16 Jan 2019, In : Trials. 20, 1, 57.

Research output: Contribution to journalArticleResearchpeer-review

Multidrug-Resistant Tuberculosis